Fundraising FoxArcus Ventures — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Exosome DiagnosticsinSeries B · Mar 2014 · $27M
BiotechHealthtechCambridge, US
James McCullough(Executive Officer, Director)William Kelly(Chief Financial Officer and Secretary of Issuer)Thomas McLain(Chief Executive Officer and Director of Issuer)Sara Barrington(Executive Officer)
BoardJoseph Boystak(Director)inGeert-Jan Mulder(Director)in
Co-investorsForbionNGN Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.